Related references
Note: Only part of the references are listed.Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration
Troels Brynskov et al.
ACTA OPHTHALMOLOGICA (2020)
Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two Regions
Mark Gillies et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2020)
Moorfields AMD database report 2: fellow eye involvement with neovascular age-related macular degeneration
Katrin Fasler et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2020)
TEN-YEAR FOLLOW-UP OF PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS
Matthew R. Starr et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2020)
Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration
Shruti Chandra et al.
EYE (2020)
One- and two-year visual outcomes from the Moorfields age-related macular degeneration database: a retrospective cohort study and an open science resource
Katrin Fasler et al.
BMJ OPEN (2019)
Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration
SriniVas R. Sadda et al.
OPHTHALMOLOGY (2018)
The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Monika Fleckenstein et al.
OPHTHALMOLOGY (2018)
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration The Comparison of Age-Related Macular Degeneration Treatments Trials
Maureen G. Maguire et al.
OPHTHALMOLOGY (2016)
Macular Atrophy Progression and 7-Year Vision Outcomes in Subjects From the ANCHOR, MARINA, and HORIZON Studies: the SEVEN-UP Study
Robert B. Bhisitkul et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2015)
Growth of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
Juan E. Grunwald et al.
OPHTHALMOLOGY (2015)
Long-Term Outcomes in Eyes Receiving Fixed-Interval Dosing of Anti-Vascular Endothelial Growth Factor Agents for Wet Age-Related Macular Degeneration
Marc C. Peden et al.
OPHTHALMOLOGY (2015)
Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration Data from an Observational Study
Mark C. Gillies et al.
OPHTHALMOLOGY (2015)
Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
Frank G. Holz et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2015)
The Neovascular Age-Related Macular Degeneration Database Report 2: Incidence, Management, and Visual Outcomes of Second Treated Eyes
Javier Zarranz-Ventura et al.
OPHTHALMOLOGY (2014)
Certification for vision impairment: researching perceptions, processes and practicalities in health and social care professionals and patients
T. Boyce et al.
BMJ OPEN (2014)
A 4-Year Longitudinal Study of 555 Patients Treated with Ranibizumab for Neovascular Age-related Macular Degeneration
Annette Rasmussen et al.
OPHTHALMOLOGY (2013)
Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
Soraya Rofagha et al.
OPHTHALMOLOGY (2013)
The estimated prevalence and incidence of late stage age related macular degeneration in the UK
Christopher G. Owen et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
Daniel F. Martin et al.
OPHTHALMOLOGY (2012)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
The Effects of a Flexible Visual Acuity-Driven Ranibizumab Treatment Regimen in Age-Related Macular Degeneration: Outcomes of a Drug and Disease Model
Frank G. Holz et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
Geeta A. Lalwani et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
David M. Brown et al.
OPHTHALMOLOGY (2009)
The natural history and prognosis of neovascular age-related macular degeneration
Tien Wong et al.
OPHTHALMOLOGY (2008)
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration
David S. Boyer et al.
OPHTHALMOLOGY (2007)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
